Christopher R Sudfeld1, Ashley Buchanan2, Nzovu Ulenga3,4, Donna Spiegelman1,5,6,7, Expeditho Mtisi3, Ellen Hertzmark1, Aisa N Muya3, David Sando1, Ester Mungure1, Mucho Mizinduko1,8, Wafaie W Fawzi1,6,7. 1. Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 2. Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, New York, USA. 3. Management and Development for Health, Dar es Salaam, Tanzania. 4. Department of Immunology and Infectious Diseases. 5. Department of Biostatistics. 6. Department of Epidemiology. 7. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. 8. Department of Epidemiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Abstract
OBJECTIVE: The objective of this study was to assess the effectiveness of a routine multivitamin supplementation program for adults living with HIV in Tanzania. DESIGN: We conducted a retrospective cohort study of 67 707 adults enrolled in the Dar es Salaam HIV care and treatment program during 2004-2012. METHODS: The Dar es Salaam HIV care and treatment program intended to provide all adult patients with multivitamin supplements (vitamins B-complex, C, and E) free of charge; however, intermittent stockouts and other implementation issues did not afford universal coverage. We use Cox proportional hazard models to assess the time-varying association of multivitamin supplementation with mortality and clinical outcomes. RESULTS: The study cohort contributed 41 540 and 129 315 person-years of follow-up time to the antiretroviral therapy (ART)-naive and ART-experienced analyses, respectively. Among 48 207 ART-naive adults, provision of multivitamins reduced the risk of mortality [adjusted hazard ratio (aHR): 0.69; 95% confidence interval (CI): 0.59-0.81], incident tuberculosis (TB) (aHR: 0.83; 0.76-0.91), and meeting ART eligibility criteria (aHR: 0.78; 95% CI: 0.73-0.83) after adjustment for time-varying confounding. Among 46 977 ART-experienced patients, multivitamins reduced mortality (hazard ratio: 0.86; 95% CI: 0.80-0.92), incident TB (aHR: 0.78; 95% CI: 0.73-0.84), and immunologic failure (aHR: 0.70; 95% CI: 0.67-0.73). The survival benefits associated with provision multivitamins appeared to be greatest during the first year of ART and declined over time (P value <0.001). CONCLUSION: Multivitamin supplementation appears to be a simple, effective, safe, and scalable program to improve survival, reduce incidence of TB, and improve treatment outcomes for adult HIV patients in Tanzania.
OBJECTIVE: The objective of this study was to assess the effectiveness of a routine multivitamin supplementation program for adults living with HIV in Tanzania. DESIGN: We conducted a retrospective cohort study of 67 707 adults enrolled in the Dar es Salaam HIV care and treatment program during 2004-2012. METHODS: The Dar es Salaam HIV care and treatment program intended to provide all adult patients with multivitamin supplements (vitamins B-complex, C, and E) free of charge; however, intermittent stockouts and other implementation issues did not afford universal coverage. We use Cox proportional hazard models to assess the time-varying association of multivitamin supplementation with mortality and clinical outcomes. RESULTS: The study cohort contributed 41 540 and 129 315 person-years of follow-up time to the antiretroviral therapy (ART)-naive and ART-experienced analyses, respectively. Among 48 207 ART-naive adults, provision of multivitamins reduced the risk of mortality [adjusted hazard ratio (aHR): 0.69; 95% confidence interval (CI): 0.59-0.81], incident tuberculosis (TB) (aHR: 0.83; 0.76-0.91), and meeting ART eligibility criteria (aHR: 0.78; 95% CI: 0.73-0.83) after adjustment for time-varying confounding. Among 46 977 ART-experienced patients, multivitamins reduced mortality (hazard ratio: 0.86; 95% CI: 0.80-0.92), incident TB (aHR: 0.78; 95% CI: 0.73-0.84), and immunologic failure (aHR: 0.70; 95% CI: 0.67-0.73). The survival benefits associated with provision multivitamins appeared to be greatest during the first year of ART and declined over time (P value <0.001). CONCLUSION: Multivitamin supplementation appears to be a simple, effective, safe, and scalable program to improve survival, reduce incidence of TB, and improve treatment outcomes for adult HIVpatients in Tanzania.
Authors: Odilon de Souza Júnior; Arício Treitinger; Giovana Lotici Baggio; Cleonice Michelon; Júlio Cesar Verdi; Joel Cunha; Silvia I A C P Ferreira; Celso Spada Journal: Clin Chem Lab Med Date: 2005 Impact factor: 3.694
Authors: Hester H Vorster; Annamarie Kruger; Barrie M Margetts; Christina S Venter; H Salomé Kruger; Frederick J Veldman; Una E Macintyre Journal: Public Health Nutr Date: 2004-12 Impact factor: 4.022
Authors: Martin W G Brinkhof; Andrew Boulle; Ralf Weigel; Eugène Messou; Colin Mathers; Catherine Orrell; François Dabis; Margaret Pascoe; Matthias Egger Journal: PLoS Med Date: 2009-04-28 Impact factor: 11.069
Authors: Derrick Yam; Adam R Aluisio; Shiromi M Perera; Jillian L Peters; Daniel K Cho; Stephen B Kennedy; Moses Massaquoi; Foday Sahr; Michael A Smit; Lindsey Locks; Tao Liu; Adam C Levine Journal: Afr J Emerg Med Date: 2020-01-03
Authors: Sabina F Mugusi; David Sando; Ferdinand M Mugusi; Claudia Hawkins; Said Aboud; Wafaie W Fawzi; Christopher R Sudfeld Journal: J Int Assoc Provid AIDS Care Date: 2019 Jan-Dec